Ep. 196 - CAR T's Next Act & Hudson's Vision for Sanofi

Ep. 196 - CAR T's Next Act & Hudson's Vision for SanofiПодробнее

Ep. 196 - CAR T's Next Act & Hudson's Vision for Sanofi

Future perspectives in CAR-T therapyПодробнее

Future perspectives in CAR-T therapy

CD19 CAR T-Cell Therapy | Revolutionizing Cancer Treatment | Michel Sadelain’s "Living Drugs"Подробнее

CD19 CAR T-Cell Therapy | Revolutionizing Cancer Treatment | Michel Sadelain’s 'Living Drugs'

Challenges in the clinical implementation of the CAR T-cell therapy A2B694Подробнее

Challenges in the clinical implementation of the CAR T-cell therapy A2B694

Investigating CAR T-cell therapy in the treatment of MSПодробнее

Investigating CAR T-cell therapy in the treatment of MS

Integration of CAR T-cell therapy: working with industryПодробнее

Integration of CAR T-cell therapy: working with industry

Monitoring Health After CAR T-Cell Therapy | What to ExpectПодробнее

Monitoring Health After CAR T-Cell Therapy | What to Expect

Dr. Sehgal on Managing CRS and Neurotoxicity From CAR T-Cell TherapyПодробнее

Dr. Sehgal on Managing CRS and Neurotoxicity From CAR T-Cell Therapy

CART19-BE-01 trial: next-generation CAR T-cell therapy for CD19+ R/R leukemia and lymphomaПодробнее

CART19-BE-01 trial: next-generation CAR T-cell therapy for CD19+ R/R leukemia and lymphoma